| scholarly article | Q13442814 |
| P50 | author | Paul Ridker | Q7153226 |
| Meir J. Stampfer | Q80164992 | ||
| Charles H Hennekens | Q89527500 | ||
| P2093 | author name string | Ma J | |
| P2860 | cites work | Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 |
| Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 | ||
| Epidemiological characteristics of platelet aggregability. | Q34489552 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine | Q40518648 | ||
| The role of fibrinogen as a cardiovascular risk factor | Q40819190 | ||
| Fibrinogen: its role in the hemostatic regulation in atherosclerosis | Q40837683 | ||
| Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study | Q41206667 | ||
| Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys | Q41830774 | ||
| A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction | Q43603017 | ||
| Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | Q43950275 | ||
| The effect of physiological levels of fibrinogen on platelet aggregation | Q44676091 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients | Q68462976 | ||
| Fibrinogen and pentoxifylline | Q69731927 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Coagulation factors and the progress of coronary heart disease | Q69904817 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin | Q72202598 | ||
| Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73994849 | ||
| [Rapid physiological coagulation method in determination of fibrinogen] | Q74515389 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 1347-1352 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study | |
| P478 | volume | 33 |
| Q33633625 | A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo |
| Q45060767 | A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. |
| Q43787052 | A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study |
| Q34601733 | Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? |
| Q24242191 | Antioxidant supplements for preventing gastrointestinal cancers |
| Q24245704 | Antioxidant supplements for preventing gastrointestinal cancers |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q28195648 | Aspirin and inflammatory markers in patients with coronary disease |
| Q28200267 | Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables |
| Q43919582 | Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). |
| Q35544330 | Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction |
| Q35565498 | Combined oral contraceptives and the risk of myocardial infarction. |
| Q39239230 | Comparison of hemorheological changes in patients after acute coronary events, intervention and ambulatory rehabilitation |
| Q50515751 | Detailed evaluation of a newly attained fungal pigment from Monascus purpureus in meat burgers. |
| Q44019577 | Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study |
| Q34248508 | Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial |
| Q44877647 | Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation |
| Q50452772 | Evaluation of fluid warmer safety using hemorheologic analysis with outdated human blood. |
| Q40301622 | Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study |
| Q35677944 | Fibrinogen--marker or mediator of vascular disease? |
| Q52860275 | Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. |
| Q34973446 | High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment |
| Q51049444 | Human cardiomyocyte interaction with electrospun fibrinogen/gelatin nanofibers for myocardial regeneration. |
| Q47654650 | Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease |
| Q54964445 | Influence of age and normal plasma fibrinogen levels on flow-mediated dilation in healthy adults |
| Q64058650 | Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease |
| Q38546311 | Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure. |
| Q73837005 | Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study |
| Q38810790 | Pleiotropic effects of niacin: Current possibilities for its clinical use. |
| Q40582543 | Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study |
| Q33857984 | Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors |
| Q42137305 | Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin |
| Q77931282 | Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease |
| Q33220405 | Short term changes in lung function, leukocytosis in blood, and lachrymal fluid among bacterial single cell protein workers after an episode with high exposure to endotoxins |
| Q41894087 | Structural effects of methionine oxidation on isolated subdomains of human fibrin D and αC regions |
| Q54417329 | Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene. |
| Q35738921 | The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases |
| Q53441808 | The relationship between attendance at religious services and cardiovascular inflammatory markers. |
| Q37082872 | The role of hemorheological factors in cardiovascular medicine |
| Q37927179 | The role of intima-media-thickness, ankle-brachial-index and inflammatory biochemical parameters for stroke risk prediction: a systematic review |
| Q44109228 | Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration |
| Q73540801 | [Genetic risk factors for myocardial infarct] |
Search more.